Literature DB >> 11139341

Bcl-2 inhibits apoptosis induced by mitochondrial uncoupling but does not prevent mitochondrial transmembrane depolarization.

J S Armstrong1, K K Steinauer, J French, P L Killoran, J Walleczek, J Kochanski, S J Knox.   

Abstract

Bcl-2 overexpression protects cells from apoptosis induced by many cytotoxic agents. In this study, we investigated the effects of uncoupling mitochondrial electron transport in both HL60 wild-type and Bcl-2-overexpressing cells using the protonophore carbonyl cyanide m-chlorophenylhydrazone. We found that uncoupling mitochondrial electron transport induced apoptosis in wild-type, but not in Bcl-2-overexpressing cells. To investigate the mechanism of action of Bcl-2-mediated inhibition of cyanide m-chlorophenylhydrazone-induced apoptosis, we measured the mitochondrial transmembrane potential (DeltaPsi(m)) after uncoupling mitochondrial electron transport and found that both HL-60 wild-type and Bcl-2-overexpressing cells similarly depolarize following cyanide m-chlorophenylhydrazone exposure. Western blot analysis demonstrated that Bcl-2 overexpression did not completely block cytochrome c release from mitochondria after uncoupling mitochondrial electron transport. Since Bcl-2 may act as an antioxidant, we studied the effect of altering the cellular redox state prior to uncoupling mitochondrial electron transport in Bcl-2-overexpressing cells. Depletion of mitochondrial (but not cytosolic) glutathione induced apoptosis in Bcl-2-overexpressing cells and negated the protective effect of Bcl-2. Furthermore, following glutathione depletion, Bcl-2-overexpressing cells were sensitized to undergo cyanide m-chlorophenylhydrazone-induced apoptosis. These data suggest that the action of Bcl-2 is dependent, in part, on the cellular and mitochondrial redox state. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11139341     DOI: 10.1006/excr.2000.5091

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  As(2)O(3) enhances retroviral reverse transcription and counteracts Ref1 antiviral activity.

Authors:  Lionel Berthoux; Greg J Towers; Cagan Gurer; Paolo Salomoni; Pier Paolo Pandolfi; Jeremy Luban
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

2.  Slow non-specific accumulation of 2'-deoxy and 2'-O-methyl oligonucleotide probes at mitochondria in live cells.

Authors:  Won Jong Rhee; Gang Bao
Journal:  Nucleic Acids Res       Date:  2010-02-10       Impact factor: 16.971

3.  Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA.

Authors:  Lionel Berthoux; Sarah Sebastian; Elena Sokolskaja; Jeremy Luban
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Chelerythrine induces apoptosis through a Bax/Bak-independent mitochondrial mechanism.

Authors:  Kah Fei Wan; Shing-Leng Chan; Sunil Kumar Sukumaran; Mei-Chin Lee; Victor C Yu
Journal:  J Biol Chem       Date:  2008-01-29       Impact factor: 5.157

5.  Nerve growth factor potentiates p53 DNA binding but inhibits nitric oxide-induced apoptosis in neuronal PC12 cells.

Authors:  Christopher Brynczka; Bruce Alex Merrick
Journal:  Neurochem Res       Date:  2007-06-26       Impact factor: 3.996

6.  Vital function of PRELI and essential requirement of its LEA motif.

Authors:  M R McKeller; S Herrera-Rodriguez; W Ma; B Ortiz-Quintero; R Rangel; C Candé; J C Sims-Mourtada; V Melnikova; C Kashi; L M Phan; Z Chen; P Huang; K Dunner; G Kroemer; K K Singh; H Martinez-Valdez
Journal:  Cell Death Dis       Date:  2010       Impact factor: 8.469

Review 7.  Fatty Acid Metabolism, Bone Marrow Adipocytes, and AML.

Authors:  Yoko Tabe; Marina Konopleva; Michael Andreeff
Journal:  Front Oncol       Date:  2020-02-18       Impact factor: 6.244

8.  Mitochondrial uncoupling and the reprograming of intermediary metabolism in leukemia cells.

Authors:  Juliana Vélez; Numsen Hail; Marina Konopleva; Zhihong Zeng; Kensuke Kojima; Ismael Samudio; Michael Andreeff
Journal:  Front Oncol       Date:  2013-04-02       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.